Evidence map›Paper›PMID 37280113›Full record

Trial reportNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2023

Reengagement for Long-Term Smoking-Cessation In Military Personnel, Retirees, Family Members (TRICARE): A Randomized Trial.

Robert C Klesges, G Wayne Talcott, Melissa A Little, Indika V Mallawaarachchi, X-Q Wang, Chase A Aycock, Marc A Patience, Jennifer P Halbert, Kara P Wiseman, Jon O Ebbert

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Robert C KlesgesDepartment of Public Health Sciences, University of Virginia School of Medicine, Charlottesville, VA, USA.ORCID 0000-0003-1314-5092
G Wayne TalcottDepartment of Public Health Sciences, University of Virginia School of Medicine, Charlottesville, VA, USA.
Melissa A LittleDepartment of Public Health Sciences, University of Virginia School of Medicine, Charlottesville, VA, USA.ORCID 0000-0002-0562-4010
Indika V MallawaarachchiDivision of Biostatistics, Department of Public Health Sciences, University of Virginia School of Medicine, Charlottesville, VA, USA.
X-Q WangDivision of Biostatistics, Department of Public Health Sciences, University of Virginia School of Medicine, Charlottesville, VA, USA.
Chase A AycockDepartment of Public Health Sciences, University of Virginia School of Medicine, Charlottesville, VA, USA.
Marc A PatienceMalcolm Grow Medical Clinics and Surgical Center, Mental Health Clinic, Joint Base Andrews, MD, USA.
Jennifer P HalbertDepartment of Public Health Sciences, University of Virginia School of Medicine, Charlottesville, VA, USA.
Kara P WisemanDepartment of Public Health Sciences, University of Virginia School of Medicine, Charlottesville, VA, USA.
Jon O EbbertDivision of Primary Care Internal Medicine, Mayo Clinic, Rochester, MN, USA.

Funding

Enhancing the Efficacy of a Smoking Quit Line in the MilitaryR01HL123978 · NHLBI · UNIVERSITY OF VIRGINIA · PI KLESGES, ROBERT C · 2014 to 2018
$3.6M
6 · The paper itself

Abstract

introductionWe sought to determine what type of treatment reengagement after smoking relapse would increase long-term cessation. AIMS AND

methodsParticipants were military personnel, retirees, and family members (TRICARE beneficiaries) recruited across the United States from August 2015 through June 2020. At baseline, consented participants (n = 614) received a validated, four-session, telephonic tobacco-cessation intervention with free nicotine replacement therapy. At the 3-month follow-up, 264 participants who failed to quit or relapsed were offered the opportunity to reengage in cessation. Of these, 134 were randomized into three reengagement conditions: (1) repeat initial intervention ("recycle"), (2) Smoking reduction with eventual cessation goal ("rate reduction"), or (3) Choose #1 or #2 ("choice"). Prolonged abstinence and 7-day point prevalence abstinence were measured at 12 months.

resultsDespite being in a clinical trial advertised as having the opportunity for reengagement, only 51% (134 of the 264) of participants who still smoked at 3-month follow-up were willing to reengage. Overall, participants randomized to recycle had higher prolonged cessation rates at 12 months than rate reduction conditions (OR = 16.43, 95% CI: 2.52 to 107.09, Bonferroni adjusted p = .011). When participants who randomly received recycle or rate reduction were pooled, respectively, with participants who chose recycle or rate reduction in the Choice group, recycle had higher prolonged cessation rates at 12 months than rate reduction (OR = 6.50, 95% CI: 1.49 to 28.42, p = .013).

conclusionsOur findings suggest service members and their family members who fail to quit smoking but are willing to reengage in a cessation program are more likely to benefit from repeating the same treatment. IMPLICATIONS: Finding methods that are both successful and acceptable to reengage people who smoke who want to quit can have a significant impact on improving the health of the public by reducing the portion of the population who smoke. This study suggests that repeating established cessation programs will result in more people ready to quit successfully achieving their goal.

Indexed as

Military PersonnelSmoking CessationSmoking ReductionFamilyHumansNicotineNicotinic AgonistsTobacco Use Cessation DevicesNicotineNicotinic Agonists

Identifiers

PMID37280113
PMCPMC10445251

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.